Time course of antiproteinuric effect of aliskiren in arterial hypertension associated with type 2 diabetes and microalbuminuria.

Fogari R, Mugellini A, Zoppi A, Preti P, Maffioli P, Perrone T, Derosa G

DOI: 10.1517/14656566.2013.772981
Published: 2013 Mar
Container: Expert opinion on pharmacotherapy
Publisher: Not recorded
Open access: no

Credibility signals

serious concern Score 25/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
serious concernRetraction Watch expression of concern: 1 expression of concern notice matched this DOI. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1517/14656566.2013.772981,
  title = {Time course of antiproteinuric effect of aliskiren in arterial hypertension associated with type 2 diabetes and microalbuminuria.},
  author = {Fogari R and Mugellini A and Zoppi A and Preti P and Maffioli P and Perrone T and Derosa G},
  year = {2013},
  journal = {Expert opinion on pharmacotherapy},
  doi = {10.1517/14656566.2013.772981},
  url = {https://doi.org/10.1517/14656566.2013.772981}
}

RIS

TY  - JOUR
TI  - Time course of antiproteinuric effect of aliskiren in arterial hypertension associated with type 2 diabetes and microalbuminuria.
AU  - Fogari R
AU  - Mugellini A
AU  - Zoppi A
AU  - Preti P
AU  - Maffioli P
AU  - Perrone T
AU  - Derosa G
PY  - 2013
JO  - Expert opinion on pharmacotherapy
DO  - 10.1517/14656566.2013.772981
UR  - https://doi.org/10.1517/14656566.2013.772981
ER  -

APA

R, F., A, M., A, Z., P, P., P, M., T, P., & G, D. (2013). Time course of antiproteinuric effect of aliskiren in arterial hypertension associated with type 2 diabetes and microalbuminuria.. Expert opinion on pharmacotherapy. https://doi.org/10.1517/14656566.2013.772981

Source records

pubmed · retrieved 2026-09-25T15:03:52.597Z
europe-pmc · retrieved 2026-09-25T15:03:52.601Z